HEMATOLOGICAL ONCOLOGY SCISCIE
血液肿瘤学
0278-0232
Quarterly
No
HEMATOL ONCOL
1983
136
ENGLAND
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1069
>12周，或约稿审稿时间
较易平均录用比例
3.9影响因子
血液学小学科
23/98JIF RANK
2507总被引频次
0278-0232
Quarterly
No
HEMATOL ONCOL
1983
136
ENGLAND
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1069
>12周，或约稿审稿时间
较易平均录用比例
3.9影响因子
血液学小学科
23/98JIF RANK
2507总被引频次
血液肿瘤学将考虑发表有关造血和淋巴系统恶性疾病的实验和临床方面的文章。现邀请涉及以下领域的手稿：急慢性白血病、恶性淋巴瘤、异基因和自体干细胞移植、造血和淋巴细胞生成、细胞因子、流行病学、病理学、分子生物学、分子遗传学、细胞遗传学
https://mc.manuscriptcentral.com/hon
Hematological Oncology will consider for publication articles dealing with experimental and clinical aspects of malignant diseases of the hemopoietic and lymphoid systems. Manuscripts dealing with the following areas are invited: Acute and chronic leukemias Malignant lymphomas Allogeneic and autologous stem cell transplantation Hematopoiesis and lymphopoiesis Cytokines Epidemiology Pathology Molecular biology Molecular genetics Cytogenetics
